COLLCollegium Pharmaceutical, Inc.

$22.06-38% 1Y

Is it safe?

Mixed

Solid, nothing alarming. Balance sheet to watch, no accounting flags, quality moderate.

1 good, 3 neutral, 2 without data
SurvivalGrey zone

Mixed, watch the balance sheet Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Honest booksLow risk

Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).

Quality6 / 9

Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.

Drawdown risk42% volderived · Oct 9, 2026

Moderate price swings, typical volatility. Worst drawdown -65% · now 56% below its 52-week high.

Unless marked, from SEC EDGAR, as of Dec 31, 2025.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitymiddle of the market
Max drawdownmiddle of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can COLL take a bad year?

The deepest fall in COLL's price history on file is −65%; it is 56% below its high today.

1.43

Altman Z-score · distress below 1.8 · safe above 3 · distress zone, the model puts this in the bankruptcy range

Interest cover
2.06×

Interest cover · operating profit covers the interest bill, with room to spare

Annualised volatility
42%

Annualised volatility · roughly twice as jumpy as the market

Worst drawdown on file
−65%

Worst drawdown on file · −56% today

Details›
Cash and short-term investments
$129M
EBITDA, trailing twelve months
$162M
Operating profit, trailing twelve months
$157M
Annualised volatilitytwo years of daily moves
42%
Worst drawdown on file
−65%
Below its 52-week high
56%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.